Using Art to Advertise with The California Sunday Magazine and Dropbox Paper
When Dropbox wanted to advertise their product, "Dropbox Paper," they were looking to tap into the young creatives market. Dropbox turned to The California Sunday Magazine, but instead of taking out an ad in their paper, Dropbox went a more creative route by creating an ad that illustrates the process of using Dropbox Paper.
Dropbox Paper teamed up with the weekend magazine to show how creatives can collaborate from all corners of the world through the cloud. The project resulted in three unique films, created by 25 individuals, across 3 continents, and 6 different time zones. These team members never met, but were still able to create together.
Chas Edwards, President and Publisher of The California Sunday Magazine, joins Cheddar to explain how this initiative is an illustration of where the advertising world is going. Consumers don't want to be served ads, they want to consume more content.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Federal Reserve Chair Jerome Powell was tricked into an extended phone call in January with Russian pranksters posing as Ukrainian President Volodymyr Zelenskyy, during which Powell appeared to discuss the economic impact of interest rate hikes.
Amazon on Thursday reported stronger-than-expected revenue and profits for the first quarter, sending its stocks higher in after-hours trading. But its prices took a dip in the evening amid concerns about a continued slowdown in the company's profitable cloud computing unit AWS.
A key index of underlying inflation that is closely followed by the Federal Reserve remained elevated last month, keeping the Fed on track to raise interest rates next week for the 10th time since March of last year.
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
